explore -WSS

explore

author：fashion 2025-09-07 06:46:33 - browse：11977

UCB website -- health policy coverage from STAT — Adobe

WASHINGTON — UCB left BIO at the end of 2023, the second major member company to exit after Pfizer pulled out as well.

UCB, headquartered in Belgium, decided not to renew its BIO membership after a routine evaluation of its engagement in trade associations, said company spokesperson Erica Puntel.

Newsletters

Sign up for D.C. Diagnosis

Washington never stops. Cut through the noise with our essential updates on health care politics and policy

Please enter a valid email address. Privacy Policy

Pfizer, whose departure STAT reported first, was listed on BIO’s website as a sponsor at one of the group’s highest levels. Pfizer bought Global Blood Therapeutics, which current BIO Board Chair Ted Love led to the approval of a drug to treat sickle cell disease, in 2022.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

WSS

A protest over insulin prices is seen as a fight for life

340B reform proposal comes out of Senate working group

Personalized medicine goes far beyond genetics

Unique patient identifier: Experts argue the benefits, pitfalls

Unique patient identifier: Experts argue the benefits, pitfalls

2 officers injured in shooting in Orlando, police say

leisure time

explore

Sign up for D.C. Diagnosis

Wikipedia

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Alnylam reports growth in sales of rare disease treatments

In age of alternative facts, a scholarly course on calling out crap

The CDC's new social media misinformation war

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Devoted Health’s losses in Medicare Advantage persist

Supreme Court strikes down use of affirmative action

How to ethically and practically extend health care to all

Affirmative action in medical school literally saved lives

Cano Health’s bankruptcy is a warning for Medicare Advantage

explore

Problems with a popular proposal to regulate AI in health care

What’s missing from the debate over nursing home staff minimums

The Biogen Aduhelm mess could happen again

'Null' research findings aren't empty of meaning. Let's publish them

Updated Covid vaccine has 54% effectiveness, new study suggests

Late stage cancers on the rise after pandemic delayed screenings

entertainment

Wikipedia

leisure time

focus